Bacterial chondronecrosis with osteomyelitis (BCO) lameness is the most prevalent skeletal disorder in poultry, implicated by the inherent risk of the high growth rate of modern broilers. The non-synchronization of massive body mass accretion vs maturation of the structural bone induces vulnerability to bone microfracture and immunosuppression, leading to bacterial necrosis in the skeletal and thoracic vertebral bones, leg paralysis, and eventual death. BCO lameness also imposes animal welfare issues and confers food safety risks. A study in 20 broiler farms in Australia recorded 28% BCO lesions of the necropsied birds, while a study in commercial flocks in Europe reported 19% moderate-to-severe lameness symptoms. The high incidence of lameness in commercial broiler farms reduces production value and leads to a huge economic loss in the poultry industry. Managing BCO lameness in broiler poultry is more challenging than that of other species because the peak of lameness incidence emerges at the marketing age of broilers. Moreover, curative treatment of the affected broilers is arduous due to their larger populations but shorter production cycles. Thus, condemnation of clinically lame birds has been a common practice in broiler farms to prevent the transmission of highly contagious BCO throughout the broiler populations. This practice decreases the production value and increases the economic forfeits. Therefore, presenting intervention measures for managing and controlling BCO in broiler poultry is necessary. Knowledge of etiological agents, pathogenesis, detection, and experimental lameness models to evaluate the efficacy of the intervention measures is highly important in presenting approaches to mitigate BCO lameness. Thus, this review focuses on microbiology studies of BCO, models of creating experimental lameness, and intervention measures mitigating BCO lameness in broiler chickens.